Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, Portugal-Reference-Cited by-同舟云学术

Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, Portugal

Published:2023-03 Issue:3 Volume:29 Page:569-575
ISSN:1080-6040
Container-title:Emerging Infectious Diseases
language:
Short-container-title:Emerg. Infect. Dis.

Author:

Kislaya Irina,Casaca Pedro,Borges Vítor,Sousa Carlos,Ferreira Bibiana I.,Fonte Ana,Fernandes Eugénia,Dias Carlos Matias,Duarte Sílvia,Almeida José Pedro,Grenho Inês,Coelho Luís,Ferreira Rita,Ferreira Patrícia Pita,Borges Cláudia Medeiros,Isidro Joana,Pinto Miguel,Menezes Luís,Sobral Daniel,Nunes Alexandra,Santos Daniela,Gonçalves António Maia,Vieira Luís,Gomes João Paulo,Leite Pedro Pinto,Nunes Baltazar,Machado Ausenda,Peralta-Santos André

Publisher

Centers for Disease Control and Prevention (CDC)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference22 articles.

1. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa.;Tegally;Nat Med,2022

2. European Centre for Disease Prevention and Control. Epidemiological update: SARS-CoV-2 Omicron sub-lineages BA.4 and BA.5. 2022 [cited 2022 Jul 22]. https://www.ecdc.europa.eu/en/news-events/epidemiological-update-sars-cov-2-omicron-sub-lineages-ba4-and-ba5

3. Instituto Nacional de Saúde Doutor Ricardo Jorge. Genetic diversity of the novel coronavirus SARS-CoV-2 (COVID-19) in Portugal. 2022 Aug 23 [cited 2022 Aug 23]. https://insaflu.insa.pt/covid19

4. European Centre for Disease Prevention and Control. COVID-19 situation dashboard [cited 2022 Jul 28]. https://qap.ecdc.europa.eu/public/extensions/COVID-19/COVID-19.html#eu-eea-daily-tab

5. Protective effect of previous SARS-CoV-2 infection against Omicron BA.4 and BA.5 subvariants.;Altarawneh;N Engl J Med,2022

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Behavior Changes Underlying Phasic Shifts of SARS-CoV-2 Exposure Settings Across 3 Omicron Epidemic Waves in Hong Kong: Prospective Cohort Study;JMIR Public Health and Surveillance;2024-06-19

2. A DFTB study on the electronic response of encapsulated DNA nucleobases onto chiral CNTs as a sequencer;Scientific Reports;2024-05-11

3. Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS);Expert Review of Vaccines;2024-02-08

4. Outward looking foreign direct investment and its determinants in highly indebted Eastern African countries;PLOS ONE;2024-02-01

5. Understanding spatiotemporal patterns of COVID-19 incidence in Portugal: A functional data analysis from August 2020 to March 2022;PLOS ONE;2024-02-01